Literature DB >> 33484556

Androgen Misuse and Abuse.

David J Handelsman1,2.   

Abstract

Androgens are potent drugs requiring prescription for valid medical indications but are misused for invalid, unproven, or off-label reasons as well as being abused without prescription for illicit nonmedical application for performance or image enhancement. Following discovery and first clinical application of testosterone in the 1930s, commercialization of testosterone and synthetic androgens proliferated in the decades after World War II. It remains among the oldest marketed drugs in therapeutic use, yet after 8 decades of clinical use, the sole unequivocal indication for testosterone remains in replacement therapy for pathological hypogonadism, organic disorders of the male reproductive system. Nevertheless, wider claims assert unproven, unsafe, or implausible benefits for testosterone, mostly representing wishful thinking about rejuvenation. Over recent decades, this created an epidemic of testosterone misuse involving prescription as a revitalizing tonic for anti-aging, sexual dysfunction and/or obesity, where efficacy and safety remains unproven and doubtful. Androgen abuse originated during the Cold War as an epidemic of androgen doping among elite athletes for performance enhancement before the 1980s when it crossed over into the general community to become an endemic variant of drug abuse in sufficiently affluent communities that support an illicit drug industry geared to bodybuilding and aiming to create a hypermasculine body physique and image. This review focuses on the misuse of testosterone, defined as prescribing without valid clinical indications, and abuse of testosterone or synthetic androgens (androgen abuse), defined as the illicit use of androgens without prescription or valid indications, typically by athletes, bodybuilders and others for image-oriented, cosmetic, or occupational reasons. © Crown copyright 2021.

Entities:  

Keywords:  SARMs; aging; anabolic steroid; androgen; drug abuse; synthetic androgens; testosterone

Mesh:

Substances:

Year:  2021        PMID: 33484556     DOI: 10.1210/endrev/bnab001

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  7 in total

1.  Could Overt Diabetes Be Triggered by Abuse of Selective Androgen Receptor Modulators and Growth Hormone Secretagogues? A Case Report and Review of the Literature.

Authors:  Richard Sotorník; Roguel Suissa; Jean-Luc Ardilouze
Journal:  Clin Diabetes       Date:  2022

Review 2.  The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health.

Authors:  Marià Alemany
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

3.  Reliability of Drug History to Verify Androgen Abuse in Men.

Authors:  Nandini Shankara-Narayana; Lance Brooker; Catrin Goebel; Naomi Speers; David J Handelsman
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

4.  Potential Association Between Anabolic Androgenic Steroid Abuse and Pituitary Apoplexy: A Case Report.

Authors:  Agne Andriuskeviciute; Giulia Cossu; Adelina Ameti; Georgios Papadakis; Roy Thomas Daniel; Vincent Dunet; Mahmoud Messerer
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

5.  Sexually transmitted doping: The impact of urine contamination of semen.

Authors:  David J Handelsman; Feyrous Bacha; Marsha DeBono; Sue Sleiman; Margaret R Janu
Journal:  Drug Test Anal       Date:  2022-06-09       Impact factor: 3.234

6.  Testosterone associates differently with body mass index and age in serum and cerebrospinal fluid in men.

Authors:  Henrik Ryberg; Per Johansson; Anders Wallin; Johan F Emilsson; Elias Eriksson; Johan Svensson; Claes Ohlsson
Journal:  J Intern Med       Date:  2022-05-31       Impact factor: 13.068

Review 7.  The Illusory Case for Treatment of an Invented Disease.

Authors:  David J Handelsman
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-18       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.